+91-9660032889
+91-9660032889
support@mysiponline.com
ITI Pharma and Healthcare Fund Regular - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Very High
-
₹16.83
(1.26%)
Current NAV 15-07-2025
-
14.03%
Returns
-
Min. SIP ₹500
Min. Investment ₹5000
Fund Suitability Test
Asset Allocation (As on 31-May-2025)
Allocation of Equity and Debt Asset Classes.
- Equity 99.71%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Mid Cap | 34.93 |
| Small Cap | 33.22 |
| Large Cap | 30.47 |
| Others | 1.09 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Healthcare
Basic Materials
Industrials
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 15-Jul-2025 |
Holdings | PE Ratio 15-Jul-2025 |
1Y Return |
|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Large Cap | Healthcare (40.14) | 15.18% | 37.97 | 9.09% |
| Divi's Laboratories Ltd | Large Cap | Healthcare (39.48) | 9.12% | 82.88 | 49.3% |
| Max Healthcare Institute Ltd Ordinary Shares | Mid Cap | Healthcare (47.09) | 5.42% | 113.57 | 36.52% |
| Lupin Ltd | Mid Cap | Healthcare (132.95) | 5.4% | 167.31 | 197.56% |
| Apollo Hospitals Enterprise Ltd | Mid Cap | Healthcare (47.09) | 5.19% | 73.21 | 14.26% |
| Cohance Lifesciences Ltd | Small Cap | Healthcare (40.14) | 4.84% | 100.11 | 25.13% |
| Aurobindo Pharma Ltd | Mid Cap | Healthcare (40.14) | 3.93% | 19.23 | -16% |
| Torrent Pharmaceuticals Ltd | Large Cap | Healthcare (40.14) | 3.91% | 60.73 | 16.17% |
| Aster DM Healthcare Ltd Ordinary Shares | Small Cap | Healthcare (47.09) | 3.15% | 5.77 | 78.76% |
| Mankind Pharma Ltd | Mid Cap | Healthcare (40.14) | 3.04% | 54.78 | 23.05% |
| Alkem Laboratories Ltd | Mid Cap | Healthcare (38.82) | 2.87% | 57.92 | -8.63% |
| Fortis Healthcare Ltd | Mid Cap | Healthcare (47.09) | 2.43% | 78.07 | 64.79% |
| Abbott India Ltd | Mid Cap | Healthcare (40.14) | 2.33% | 0 | 20.09% |
| Wockhardt Ltd | Small Cap | Healthcare (40.14) | 2.28% | -634.95 | 118.61% |
| Granules India Ltd | Small Cap | Healthcare (39.48) | 2.11% | 22.69 | -8.86% |
| Neuland Laboratories Ltd | Small Cap | Healthcare (40.14) | 1.98% | 73.65 | 79.76% |
| FDC Ltd | Small Cap | Healthcare (39.48) | 1.55% | 30.47 | -0.11% |
| HealthCare Global Enterprises Ltd | Small Cap | Healthcare (47.09) | 1.55% | 178.65 | 58.68% |
| Supriya Lifescience Ltd | Small Cap | Healthcare (29.86) | 1.48% | 0 | 0% |
| Sumitomo Chemical India Ltd Ordinary Shares | Small Cap | Basic Materials (26.63) | 1.43% | 53.54 | 10.06% |
| Sagility India Ltd | Small Cap | Healthcare | 1.29% | - | 0% |
| Rainbow Childrens Medicare Ltd | Small Cap | Healthcare (47.09) | 1.28% | 63.33 | 25.43% |
| J.B. Chemicals & Pharmaceuticals Ltd | Small Cap | Healthcare (55.16) | 1.23% | 48.39 | 61.86% |
| Vijaya Diagnostic Centre Ltd | Small Cap | Healthcare (47.09) | 1.23% | 73.14 | 30.73% |
| Shilpa Medicare Ltd | Small Cap | Healthcare (39.48) | 1.23% | 111.3 | 33.81% |
| Dr Reddy's Laboratories Ltd | Large Cap | Healthcare | 1.22% | - | 0% |
| Gland Pharma Ltd | Small Cap | Healthcare (40.14) | 1.18% | 44.72 | -5.23% |
| GlaxoSmithKline Pharmaceuticals Ltd | Mid Cap | Healthcare (40.14) | 1.18% | 58.33 | 25.09% |
| UPL Ltd | Mid Cap | Basic Materials (26.57) | 1.14% | 59.78 | 19.2% |
| OneSource Specialty Pharma Ltd | Healthcare | 1.09% | - | 0% | |
| Caplin Point Laboratories Ltd | Small Cap | Healthcare (40.14) | 1.08% | 29.66 | 37.81% |
| Linde India Ltd | Mid Cap | Basic Materials (96.23) | 1.07% | 128.45 | -21.39% |
| Orchid Pharma Ltd | Small Cap | Healthcare (39.69) | 1.03% | 36.59 | -36.36% |
| Cipla Ltd | Large Cap | Healthcare (40.14) | 1.02% | 22.85 | -1.62% |
| Sai Life Sciences Ltd | Small Cap | Healthcare | 1.02% | - | 0% |
| Strides Pharma Science Ltd | Small Cap | Healthcare (40.14) | 1.01% | 25.09 | -0.35% |
| Laurus Labs Ltd | Small Cap | Healthcare (46.65) | 0.97% | 0 | 9.05% |
| SRF Ltd | Mid Cap | Industrials (75.97) | 0.93% | 76.48 | 34.58% |
| TTK Healthcare Ltd | Small Cap | Healthcare (40.14) | 0.32% | 0 | -4.27% |
| Emcure Pharmaceuticals Ltd | Small Cap | Healthcare | 0% | - | 0% |
| Sequent Scientific Ltd | Small Cap | Healthcare (55.16) | 0% | -657.89 | 100.38% |
Discover More with Premium Access
View Stock Information
Take test again
Chat with usFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for ITI Pharma and Healthcare Fund Regular ?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for ITI Pharma and Healthcare Fund Regular ?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.
